title: Effect of eicosapentaenoic acid ethyl on urine albumin excretion in NIDDM.
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
authors.forename: N
authors.initials: N
authors.lastname: Sato
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Kashima
authors.forename: K
authors.initials: K
authors.lastname: Ohtani
authors.forename: M
authors.initials: M
authors.lastname: Mori
mesh_terms: D000419:Albuminuria / Q000188:drug therapy*; D002214:Capsules; D003924:Diabetes Mellitus, Type 2 / Q000652:urine*; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
chemical_list: D002214:Capsules; D010975:Platelet Aggregation Inhibitors; C035276:eicosapentaenoic acid ethyl ester; D015118:Eicosapentaenoic Acid